The Leadership Team at Enlivex drives the company's strategic vision and operational execution in the field of immunotherapy. Comprising key executives such as the CEO, CFO, and Chief Scientific & Medical Officer, the team collaborates to guide research initiatives, secure funding, and navigate regulatory pathways, all with the goal of advancing Enlivex’s allogeneic drug pipeline and establishing new immune response equilibriums for patients.
View all